Description
Harvard Infectious Diseases In Adults 2026
Harvard Infectious Diseases In Adults 2026 provides a comprehensive, expert-led review of the newest approaches to preventing, diagnosing, and managing common, resistant, rare, and emerging infectious diseases in adults.
About Harvard Infectious Diseases In Adults 2026
This program provides a comprehensive, expert-led review of the most current developments in diagnosing and managing complex infectious diseases. The curriculum covers antimicrobial stewardship, emerging fungal and viral infections, HIV prevention and management, resistant organisms, adult vaccination, and multidisciplinary approaches to challenging cases.
Now in its 50th year, the course presents state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases that are common, challenging, rare, and emerging. Nationally recognized infectious disease experts and master clinicians present updates, best practices, and new guidelines with practical recommendations for daily clinical work.
Why Choose This Program
âś“ PDF resources for convenient study and clinical reference
âś“ Nationally recognized faculty in infectious diseases and related specialties
âś“ Practical clinical guidance for common, complex, rare, and emerging infections
âś“ Multidisciplinary perspectives from pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine
âś“ Case-based learning with problem-solving discussions and expert decision-making
Core Educational Focus
Highlights of the 2026 Program
Expanded Case-Based and Problem-Solving Education
The 2026 curriculum features an expanded range of interactive, case-based, and problem-solving sessions. Multidisciplinary workshops combine perspectives from infectious disease, pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine.
Complicated urinary tract infections • Intra-abdominal infections • Resistant Gram-positive infections • Resistant Gram-negative infections • Endocarditis • Cardiac device infections • Musculoskeletal infections • Nontuberculous mycobacterial infections
Highly Resistant Infections
âś“ ESBL-producing Gram-negative rods
âś“ Carbapenemase-producing Gram-negative rods, including NDM-1 organisms
âś“ Vancomycin-resistant enterococci (VRE)
âś“ Resistant Aspergillus, molds, and Candida infections
âś“ Nontuberculous mycobacteria (NTM)
Common Infectious Diseases Covered
Challenging, Rare, and Emerging Infections
Clinical Decision-Making
âś“ Rapid detection and empiric treatment of life-threatening infections
âś“ Choosing inpatient versus outpatient care
âś“ Choosing intravenous versus oral antimicrobial therapy
âś“ Optimizing empiric therapy and knowing when to de-escalate
âś“ Applying safety, quality, and practice-improvement strategies
Antimicrobial Stewardship & Practice Improvement
The program emphasizes antimicrobial stewardship to reduce resistance and cost, early inpatient infectious disease consultation to improve outcomes, and effective strategies for managing infections in persons who inject drugs.
Who Should Take This Course
Designed for physicians and advanced practice clinicians involved in adult infectious disease care, including:
âś“ Infectious Disease Specialists âś“ Internal Medicine Physicians âś“ Hospitalists
âś“ Primary Care Physicians âś“ Pharmacists âś“ Nurse Practitioners âś“ Physician Assistants
âś“ Clinicians caring for immunocompromised or medically complex patients
Format & Course Files
🎬 62 MP4 Videos
Recorded sessions covering the complete 2026 program.
đź“„ PDF Resources
Supporting educational materials for study and clinical reference.
đź’ľ 16.7 GB
Complete package size: approximately 16,700 MB.
📅 May 4–8, 2026
Original dates of the 2026 course.
Educational Use Notice: This digital package is provided for educational purposes only. No certificate or CME credit is included with this copy.
Reviews
There are no reviews yet.